insomnia phenotype
Evidence from:
primary |
all sources
Related entities (20)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| ADHD | associated_with | insomnia | — | 1 |
| alcohol | risk_factor_for | insomnia | — | 1 |
| Alcohol Use Disorder | associated_with | insomnia | 7.43e-06 | 1 |
| amplitude | associated_with | insomnia | — | 1 |
| auditory | associated_with | insomnia | 7.43e-06 | 1 |
| bipolar disorder | associated_with | insomnia | — | 1 |
| FURIN | associated_with | insomnia | — | 1 |
| gabapentin | protective_against | insomnia | — | 1 |
| insomnia | associated_with | opioid dependence | — | 1 |
| insomnia | associated_with | schizophrenia | — | 1 |
| insomnia | associated_with | withdrawal | — | 1 |
| irritability | associated_with | insomnia | — | 1 |
| light smokers | associated_with | insomnia | — | 1 |
| major depressive disorder | associated_with | insomnia | — | 1 |
| nalmefene | associated_with | insomnia | — | 1 |
| naltrexone | associated_with | insomnia | — | 1 |
| nicotine withdrawal | associated_with | insomnia | — | 1 |
| opioid dependence | associated_with | insomnia | — | 1 |
| PAU | associated_with | insomnia | — | 2 |
| withdrawal | associated_with | insomnia | — | 1 |
Mentioned in (40)
Papers in which this entity is mentioned.
- Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. (2022)
- Genetic variants associated with longitudinal changes in brain structure across the lifespan. (2022)
- Early-life nicotine or cotinine exposure produces long-lasting sleep alterations and downregulation of hippocampal corticosteroid receptors in adult mice. (2021)
- Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. (2021)
- Genetics of substance use disorders in the era of big data. (2021)
- Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions. (2021)
- Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches. (2021)
- Genome-wide association analysis of opioid use disorder: A novel approach using clinical data. (2020)
- ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. (2020)
- Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
- Sex differences in the genetic architecture of obsessive-compulsive disorder. (2019)
- Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. (2019)
- In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana. (2019)
- Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. (2019)
- Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder. (2019)
- Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. (2019)
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018)
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. (2018)
- Acquired Sleep-Related Hypermotor Epilepsy with Disrupted White Matter Tracts Assessed by Multishell Diffusion Magnetic Resonance Imaging. (2018)
- Developmental ethanol exposure-induced sleep fragmentation predicts adult cognitive impairment. (2016)
- The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review. (2014)
- Pharmacogenetics of OPRM1. (2014)
- Policy: NIH to balance sex in cell and animal studies. (2014)
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
- Gabapentin treatment for alcohol dependence: a randomized clinical trial. (2014)
- A mega-analysis of genome-wide association studies for major depressive disorder. (2013)
- COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers. (2013)
- Sleep problems in children with fetal alcohol spectrum disorders. (2012)
- Pharmacological treatment of cannabis dependence. (2011)
- Prenatal alcohol exposure: fetal programming and later life vulnerability to stress, depression and anxiety disorders. (2010)
- Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. (2009)
- On the value of homogeneous constructs for construct validation, theory testing, and the description of psychopathology. (2009)
- Novel SOX2 mutations and genotype-phenotype correlation in anophthalmia and microphthalmia. (2009)
- The influence of substance use on adolescent brain development. (2009)
- Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. (2008)
- Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. (2008)
- EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. (2008)
- Cannabis withdrawal in the United States: results from NESARC. (2008)
- GABA and glycine as neurotransmitters: a brief history. (2006)
- Impairments of brain and behavior: the neurological effects of alcohol. (1997)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| insomnia | phenotype | 40 | 64 |